Skip to main content

Table 1 Description of clinical variables

From: Single nucleotide polymorphisms in DNA repair genes as risk factors associated to prostate cancer progression

Clinical n (%)
Clinical tumor size (cT)   
cT1a – cT2a 270 (54.7)
cT2b – cT2c 141 (25.8)
cT3 – cT4 66 (13.4)
NA 17 (3.4)
Initial PSA (ng/mL)   
<10 306 (61.9)
10 – 19.99 103 (20.9)
>20 79 (16.0)
NA 6 (1.2)
Gleason score   
<7 226 (45.7)
7 195 (39.5)
>7 71 (14.4)
NA 2 (0.4)
D’Amico group   
Low 120 (24.3)
Intermediate 184 (37.2)
High 173 (35.0)
NA 17 (3.4)
  1. Abbreviations: PSA prostate specific antigen, NA not available.